Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancers

BACKGROUND: Gemcitabine plus platinum is the standard of care first-line treatment for advanced biliary tract cancers (BTC). There is no established second-line therapy, and retrospective reviews report median progression-free survival (PFS) less than 3 mo on second-line therapy. 5-Fluorouracil plus...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizrahi, Jonathan D, Gunchick, Valerie, Mody, Kabir, Xiao, Lianchun, Surapaneni, Phanikeerthi, Shroff, Rachna T, Sahai, Vaibhav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960075/
https://www.ncbi.nlm.nih.gov/pubmed/31966916
http://dx.doi.org/10.4251/wjgo.v12.i1.83

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960075/
https://www.ncbi.nlm.nih.gov/pubmed/31966916
http://dx.doi.org/10.4251/wjgo.v12.i1.83

Ejemplares similares